Combinatorial effects of thymoquinone on the anticancer activity and hepatotoxicity of the prodrug CB 1954

Scientia Pharmaceutica

Volumn 81, Issue 2, 2013, Pages 519-530

  Talib, Wamidh H ^a   Abukhader, Majed M ^a,b  

^a APPLIED SCIENCE PRIVATE UNIVERSITY   (Jordan)

^b OMAN MEDICAL COLLEGE   (Oman)

Author keywords

Anticancer drugs; Cb 1954; Liver toxicity; Nigella sativa; Thymoquinone

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; THYMOQUINONE; TRETAZICAR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; BREAST CANCER; COLORIMETRY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; LIVER FUNCTION TEST; LIVER TOXICITY; MOUSE; NECROSIS; NONHUMAN; SINGLE DRUG DOSE; TUMOR VOLUME;

EID: 84879318567     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1211-15     Document Type: Article

References (33)

1. Talib W, Mahasneh A. Combination of Ononis hirta and Bifidobacterium longum decreases syngeneic mouse mammary tumor burden and enhances immune response. J Can Res Ther. 2012; 8: 417-423. http://dx.doi.org/10.4103/0973-1482.103523
2. Rajput S, Mandal M. Antitumor promoting potential of selected phytochemicals derived from spices: a review. Eur J Cancer Prev. 2012; 21: 205-215. http://dx.doi.org/10.1097/CEJ.0b013e32834a7f0c
3. Jaganathan S, Mandal M. Antiproliferative Effects of Honey and of Its Polyphenols: A Review. J Biomed Biotechnol. 2009; 2009: 830616. http://dx.doi.org/10.1155/2009/830616
4. Alenzi F, El-Bolkiny Yel-S, Salem M. Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide. Br J Biomed Sci. 2010; 67: 20-28. http://www.ncbi.nlm.nih.gov/pubmed/20373678
5. Amacher D. Reactive intermediates and the pathogenesis of adverse drug reactions: the toxicology perspective. Curr Drug Metab. 2006; 7: 219-229. http://dx.doi.org/10.2174/138920006776359284
6. Tang M, Helsby N, Goldthorpe M, Thompson K, Al-Ali S, Tingle M. Hepatic nitroreduction, toxicity and toxicokinetics of the anti-tumour prodrug CB 1954 in mouse and rat. Toxicology. 2007; 240: 70-85. http://dx.doi.org/10.1016/j.tox.2007.07.018
7. Chung-Faye G, Palmer D, Anderson D, Clark J, Downes M, Baddeley J, Hussain S, Murray PI, Searle P, Seymour L, Harris PA, Ferry D, Kerr DJ. Virus-directed, Enzyme Prodrug Therapy with Nitroimidazole Reductase: A Phase I and Pharmacokinetic Study of its Prodrug, CB1954. Clin Cancer Res. 2001; 7: 2662-2668. http://www.ncbi.nlm.nih.gov/pubmed/11555577
8. McNeish I, Green K, Gilligan M, Ford M, Mautner V, Young L, Kerr D, Searle P. Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954. Gene Ther. 1998; 5: 1061-1069. http://dx.doi.org/10.1038/sj.gt.3300744
9. Palmer D, Mautner V, Hull D, Ellis J, Mountain A, Searle P, Young L, Gerritsen W, James N, Kerr D. Virus-directed enzyme prodrug therapy (VDEPT): a clinical trial of adenovirus-delivered nitroreductase (NTR) in combination with CB 1954 in patients with primary or secondary liver cancer. J Clin Oncol. 2005; 23: 3157. http://dx.doi.org/10.1200/JCO.2005.05.232
10. Patel P, Mautner V, Searle P,Young J, Hull D, Ellis J, Wallace, D, Leung H, Young, L, James, N. Suicide gene therapy using adenovirus encoded nitroreductase and CB 1954 in patients with locally relapsed prostate cancer. J Clin Oncol. 2005; 23 (Suppl 1): 214S.
11. Gali-Muhtasib H, Roessner A, Schneider-Stock R. Thymoquinone: A promising anti-cancer drug from natural sources. Int J Biochem Cell Biol. 2006; 38: 1249-1253. http://dx.doi.org/10.1016/j.biocel.2005.10.009
12. Das S, Dey K, Dey G, Pal I, Majumder A, MaitiChoudhury S, Kundu S, Mandal M. Antineoplastic and Apoptotic Potential of Traditional Medicines Thymoquinone and Diosgenin in Squamous Cell Carcinoma. PLoS One. 2012; 7: e46641. http://dx.doi.org/10.1371/journal.pone.0046641
13. Badary O, Taha R, Gamal el-Din A, Abdel-Wahab M. Thymoquinone is a potent superoxide anion scavenger. Drug Chem Toxicol. 2003; 26: 87-98. http://dx.doi.org/10.1081/DCT-120020404
14. Nagi M, Alam K, Badary O, al-Shabanah O, al-Sawaf H, al-Bekairi A. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int. 1999; 47: 153-159. http://www.ncbi.nlm.nih.gov/pubmed/10092955
15. Daba M, Abdel-Rahman M. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol Lett. 1998; 95: 23-29. http://dx.doi.org/10.1016/S0378-4274(98)00012-5
16. Zaoui A, Cherrah Y, Alaoui K, Mahassine N, Amarouch H, Hassar M. Effects of Nigella sativa fixed oil on blood homeostasis in rats. J Ethnopharmacol. 2002; 79: 23-26. http://dx.doi.org/10.1016/S0378-8741(01)00342-7
17. Al-Ali A, Alkhawajah A, Randhawa M, Shaikh N. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med Coll Abbottabad. 2008; 20: 25-27. http://www.ncbi.nlm.nih.gov/pubmed/19385451
18. Nagi M, Mansour M. Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol Res. 2000; 41: 283-289. http://dx.doi.org/10.1006/phrs.1999.0585
19. Gökçe A, Oktar S, Koc A, Yonden Z. Protective effects of thymoquinone against methotrexate-induced testicular injury. Hum Exp Toxicol. 2011; 30: 897-903. http://dx.doi.org/10.1177/0960327110382564
20. Al-Ghamdi M. Protective effect of Nigella sativa seeds against carbon tetrachloride-induced liver damage. Am J Chin Med. 2003; 31: 721-728. http://dx.doi.org/10.1142/S0192415X03001399
21. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957; 28: 56-63. http://www.ncbi.nlm.nih.gov/pubmed/13458125
22. Kaseb AO, Chinnakannu K, Chen D, Sivanandam A, Tejwani S, Menon M, Dou Q, Reddy G. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Cancer Res. 2007; 67: 7782-7788. http://www.ncbi.nlm.nih.gov/pubmed/17699783
23. Ivankovic S, Stojkovic R, Jukic M, Milos M, Milos M, Jurin M. The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo. Exp Oncol. 2006; 28: 220-224. http://www.ncbi.nlm.nih.gov/pubmed/17080016
24. El-Mahdy M, Zhu Q, Wang Q, Wani G, Wani A. Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int J Cancer. 2005; 117: 409-417. http://dx.doi.org/10.1002/ijc.21205
25. Gali-Muhtasib H, Diab-Assaf M, Boltze C, Al-Hmaira J, Hartig R, Roessner A, Schneider-Stock R. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol. 2004; 25: 857-866. http://www.ncbi.nlm.nih.gov/pubmed/15375533
26. Woo C, Kumar A, Sethi G, Tan K. Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway. Biochem Pharmacol. 2012; 83: 443-451. http://dx.doi.org/10.1016/j.bcp.2011.09.029
27. Effenberger-Neidnicht K, Schobert R. Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin. Cancer Chemother Pharmacol. 2011; 67: 867-874. http://dx.doi.org/10.1007/s00280-010-1386-x
28. Jafri S, Glass J, Shi R, Zhang S, Prince M, Kleiner-Hancock H. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo. J Exp Clin Cancer Res. 2010; 29: 87. http://dx.doi.org/10.1186/1756-9966-29-87
29. Nagi M, Almakki H. Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity. Phytother Res. 2009; 23: 1295-1298. http://dx.doi.org/10.1002/ptr.2766
30. Chen S, Knox R, Wu K, Deng P, Zhou D, Bianchet M, Amzel, L. Molecular basis of the catalytic differences among DT-diaphorase of human, rat and mouse. J Biol Chem. 1997; 272: 1437-1439. http://dx.doi.org/10.1074/jbc.272.3.1437
31. Walton M, Wolf C, Workman P. Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins. Int J Radiat Oncol Biol Phys. 1989; 16: 983-986. http://dx.doi.org/10.1016/0360-3016(89)90900-0
32. Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB, Liu M. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther. 2008; 7: 1789-1796. http://dx.doi.org/10.1158/1535-7163.MCT-08-0124
33. El Daly E. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatininduced toxicity in rats. J Pharm Belg. 1998; 53: 87-93. http://www.ncbi.nlm.nih.gov/pubmed/9609969